

































	 Two	 new	 quinolone	 derivatives,	 5‐nitroquinolin‐8‐yl‐3‐bromobenzoate	 (1)	 and	 5‐
nitroquinolin‐8‐yl‐3‐chlorobenzoate	 (2),	 were	 synthesized	 and	 their	 structures	 were
elucidated	 using	 X‐ray	 diffraction	 techniques.	 Both	 compounds	 crystallized	 in	 P21/n
(monoclinic)	space	group	having	four	independent	molecules	in	asymmetric	unit.	The
dihedral	 angle	 between	 benzene	 and	 planner	 quinoline	 rings	 in	 compounds	 1	 and	 2
were	 found	 to	 be	 117.7(2)	 and	 117.4(2)ᵒ,	 respectively.	 No	 intermolecular	 hydrogen
bonding	 was	 observed	 in	 compound	 1.	 However,	 C‐H···O	 intermolecular	 interaction
was	found	to	connect	the	molecules	in	crystal	lattice	of	compound	2.	Hirshfeld	surfaces
analysis	 was	 performed	 to	 evaluate	 the	 directions,	 and	 strength	 of	 interactions	 of
molecules	 of	 compounds	 and	 1	 and	 2	 with	 neighbouring	 molecules,	 and	 the	 major




weak	 antileishmanial	 activity	 against	L.	Major	promastigotes	 in	 vitro	with	 IC50	 values













Quinoline,	 also	 known	 as	 benzopyridine,	 1‐benzazine,	
benzo[b]pyridine,	 or	 benzazine,	 is	 an	 aromatic	 heterocyclic	
compound	having	fused	phenyl	and	pyridine	moieties.	Deriva‐
tives	 of	 quinolone	 have	 attracted	 attention	 of	 medicinal	
chemists	due	to	their	wide	range	of	biological	applications	[1].	




cancer	 [3],	 anti‐hypertensive	 [4],	 anti‐TB	 [5],	 anti‐inflamma‐	
tory	[6],	and	anti‐HIV	[7,8]	agents.	The	wide	range	of	biological	
activities	 prompted	 structural	 chemists	 to	 explore	 the	
substitution	pattern	of	quinoline	derivatives,	which	allows	the	
large	libraries	of	structurally	diverse	derivatives	with	interes‐
ting	 biological	 activities.	 Further	 to	 our	 interest	 in	 the	 syn‐
thesis	of	diverse	biologically	active	derivatives	of	quinoline,	we	
have	 synthesized	 5‐nitroquinolin‐8‐yl‐3‐bromobenzoate	 (1),	
and	 5‐nitroquinolin‐8‐yl‐3‐chlorobenzoate	 (2).	 Their	 struc‐
tures	 were	 studied	 by	 using	 single	 crystal	 X‐ray	 diffraction	
techniques,	 followed	 by	 detailed	 Hirshfeld	 quantitative	
analysis	of	contributions	of	various	non‐covalent	 interactions	
towards	 the	 crystal	 stability	 in	 compounds	 1	 and	 2.	 Both	
quinoline	 derivatives	 were	 also	 evaluated	 for	 their	 anti‐
leishmanial	and	anti‐bacterial	activity	 in	vitro	and	 interesting	








Analytical	 grade	 chemicals	 were	 purchased	 from	 Sigma‐	
Aldrich.	 Single	 crystal	X‐ray	diffraction	data	was	 collected	by	
using	 MoKα	 radiation	 (λ	 =	 0.71073	 Å)	 on	 a	 Bruker	 SMART	
APEX‐II	diffractometer	fitted	with	CCD	detector	at	a	tempera‐
ture	 of	 273(2)	 K.	 SAINT	 program	 was	 used	 to	 integrate	 the	
reflection	intensities	whereas,	multi‐scan	method	was	used	for	
absorption	 correction	 (SADABS)	 [9].	 Finally	 the	 structures	
were	 constructed	 by	 using	 SHELXTL	 program	 [10,11].	
PLATON	 calculations	 were	 used	 to	 find	 the	 significant	 non‐
covalent	 interactions	 in	 the	 molecule	 [12].	 Quantitative	















de	 versus	 di,	 in	 which	 cyan	 dots	 represent	 the	 area	 of	 the	
interaction	 towards	 the	 total	 Hirshfeld	 surface.	 MDR	
Escherichia	 coli	 strains	 (ATCC	35218	 and	ATCC	25922)	were	
purchased	 from	 the	 American	 Type	 Cultures	 Center	 (ATCC).	
The	duly	 characterized	Pakistani	multi‐drug	 resistant	 clinical	
isolates	 of	 E.	 coli	 (M2	 and	 M3,	 Source:	 Human	 urine)	 were	
obtained	 from	 the	Diagnostic	 Laboratory	 of	 Liaquat	National	
Hospital	 (LNH),	 Karachi,	 Pakistan.	 All	 the	 compounds	 were	





The	 constructed	 was	 solved	 and	 refined	 by	 direct	 and	
least‐square	methods,	 respectively	 [10,14].	 All	 non‐hydrogen	









slight	 modification	 [15].	 8‐Hydroxy‐5‐nitroquionoline	 (1.0	




Progress	 of	 the	 reaction	 was	 monitored	 through	 thin	 layer	
chromatography,	 after	 complete	 consumption	 of	 starting	
material,	solvent	was	evaporated	under	reduced	pressure.	The	
crude	 product	 was	 washed	 with	 mixture	 of	 hexanes:	 ethyl	





Antileishmanial	 activity	was	 performed	 by	 using	method	
described	 by	 Choudhary	 and	 co‐workers	 [16].	 Anti‐bacterial	
activity	was	performed	by	using	methods	previously	described	
by	 Siddiqui	 and	 co‐workers	 [17].	Whereas	 the	 cytotoxic	 acti‐


















The	 structures	 of	 compounds	1	 and	2	were	 found	 to	 be	






































Atom‐Atom	 Bond	lengths	[Å]	 	 Atom‐Atom	 Bond	lengths	[Å]	 	
Br(1)‐C(14)	 1.885	(2)	 C(3)‐C(4)	 1.426(3)	
O(3)‐C(11)		 1.365	(3)	 C(4)‐C(5)	 1.412(3)	
O(3)‐C(10)		 1.392(2)	 C(4)‐C(9)	 1.426(3)	
O(4)‐C(11)		 1.193(3)	 C(9)‐C(10)	 1.415(3)	
O(1)‐N(1)		 1.206(3)	 C(13)‐C(14) 1.378(3)	
N(2)‐C(7)		 1.314(3)	 C(10)‐C(1)		 1.350(3)	
N(2)‐C(9)		 1.360(3)	 C(16)‐C(15)		 1.370(4)	
N(1)‐O(2)		 1.220(3)	 C(16)‐C(17)		 1.388(3)	
N(1)‐C(3)		 1.471(3)	 C(5)‐C(6)	 1.357(4)	
C(12)‐C(13)		 1.386(3)	 C(14)‐C(15)	 1.385(4)	
C(12)‐C(17)		 1.387(3)	 C(2)‐C(1)	 1.401(3)	
C(12)‐C(11)		 1.486(3)	 C(7)‐C(6)	 1.400(4)	
C(3)‐C(2)		 1.351(3)	
Atom‐Atom‐Atom	 Bond	angles	[ᵒ]	 Atom‐Atom‐Atom	 Bond	angles	[ᵒ]	
C(11)‐O(3)‐C(10)		 117.66(17)	 O(4)‐C(11)‐C(12)	 125.6(2)	
C(7)‐N(2)‐C(9)		 117.4(2)	 O(3)‐C(11)‐C(12)		 110.90(17)	
O(1)‐N(1)‐O(2)		 122.6(2)	 C(14)‐C(13)‐C(12)	 119.0(2)	
O(1)‐N(1)‐C(3)		 118.8(2)	 C(1)‐C(10)‐O(3)		 118.4(2)	
O(2)‐N(1)‐C(3)		 118.5(2)	 C(1)‐C(10)‐C(9)		 122.6(2)	
C(13)‐C(12)‐C(17)		 120.1(2)	 O(3)‐C(10)‐C(9)	 118.8(2)	
C(13)‐C(12)‐C(11)		 121.23(19)	 C(15)‐C(16)‐C(17)	 120.9(2)	
C(17)‐C(12)‐C(11)		 118.61(19)	 C(12)‐C(17)‐C(16)	 119.6(2)	
C(2)‐C(3)‐C(4)		 122.7(2)	 C(6)‐C(5)‐C(4)	 119.7(2)	
C(2)‐C(3)‐N(1)		 116.0(2)	 C(13)‐C(14)‐C(15)	 121.5(2)	
C(4)‐C(3)‐N(1)		 121.2(2)	 C(13)‐C(14)‐Br(1)	 118.71(18)	
C(5)‐C(4)‐C(9)		 116.2(2)	 C(15)‐C(14)‐Br(1)	 119.77(17)	
C(5)‐C(4)‐C(3)		 127.5(2)	 C(3)‐C(2)‐C(1)		 120.5(2)	
C(9)‐C(4)‐C(3)		 116.30(19)	 C(16)‐C(15)‐C(14)		 118.9(2)	
N(2)‐C(9)‐C(10)		 117.81(19)	 C(10)‐C(1)‐C(2)		 119.0(2)	
N(2)‐C(9)‐C(4)		 123.4(2)	 N(2)‐C(7)‐C(6)		 123.6(2)	




tuted	 benzene	 rings	 (C11‐C16)	 linked	 to	 each	 other	 by	
carboxylate	bridges	(C10/O3/O4),	represented	in	Figure	2	and	
3.	 The	 dihedral	 angles	 between	 the	 planner	 quinoline	 and	
benzene	 rings	were	 found	 to	 be	 117.7(2)	 and	 117.4	 (2)ᵒ	 for	
compounds	1	and	2,	respectively.	
In	 compound	 1,	 no	 inter‐	 and	 intra‐molecular	 hydrogen	
bondings	 were	 observed,	 and	 molecules	 were	 found	 to	 be	
arranged	 in	 three	 dimensions	 (Figure	 4).	 Similarly	 in	
compound	 2	 no	 classical	 hydrogen	 bonding	 was	 observed.	
However,	two	neighboring	molecules	were	found	to	be	linked	
through	 C14‐H14A···O1	 intermolecular	 hydrogen	 bond	 with	
donor	 acceptor	 distance	 3.4813	 Å	 and	 angle	 of	 16°,	




The	 quantitative	 Hirshfeld	 surface	 calculations	 to	 predict	
the	 directions	 and	 strength	 of	 interactions	 with	 neighboring	
molecules	 was	 carried	 both	 for	 compounds	 1	 and	 2.	 The	
circular	 red	 regions	 generated	Hirshfeld	 indicated	 the	 strong	
O···H	 hydrogen‐bonds	 that	 can	 be	 easily	 observed	 in	
compound	 2	 as	 compared	 to	 compound	 1	 (Figure	 6	 and	 7).	
The	 two‐dimensional	 fingerprint	 plot	 (Figure	 8	 and	 9)	 of	
Hirshfeld	 of	 compounds	 1	 and	 2	 represent	 the	 percent	
contacts	 contributed	 towards	 crystal	 packing	 as	 depicted	 in	







Atom‐Atom	 Bond	lengths	[Å]	 Atom‐Atom Bond	lengths	[Å]	 	
O(3)‐C(11)		 1.365(3)		 C(12)‐C(13)	 1.381(3)	
O(3)‐C(10)	 1.394(3)	 C(12)‐C(17)		 1.383(3)	
C(4)‐C(5)	 1.415(3)	 C(12)‐C(11)		 1.485(3)	
C(4)‐C(9)		 1.420(3)	 C(3)‐C(2)	 1.351(4)	
C(4)‐C(3)	 1.425(3)	 N(2)‐C(7)	 1.309(3)	
O(4)‐C(11)	 1.188(3)	 C(13)‐C(14) 1.381(3)	
C(10)‐C(1)	 1.348(4)	 C(5)‐C(6) 1.352(4)	
C(10)‐C(9)		 1.409(3)	 C(7)‐C(6)	 1.397(4)	
C(9)‐N(2)		 1.366(3)	 C(1)‐C(2) 1.393(4)	
N(1)‐O(1)	 1.218(3)	 C(17)‐C(16) 1.378(4)	
N(1)‐O(2)		 1.219(3)	 C(14)‐C(15)	 1.379(4)	
N(1)‐C(3)	 1.477(3)	 C(16)‐C(15)	 1.369(4)	
Atom‐Atom‐Atom	 Bond	angles	[ᵒ]	 Atom‐Atom‐Atom Bond	angles	[ᵒ]	
C(11)‐O(3)‐C(10)		 117.45(19)		 C(2)‐C(3)‐N(1)		 116.4(2)	
C(5)‐C(4)‐C(9)	 116.4(2)	 O(4)‐C(11)‐O(3)	 123.7(2)		
C(5)‐C(4)‐C(3)	 127.6(2)	 O(4)‐C(11)‐C(12)		 125.7(2)	
C(9)‐C(4)‐C(3)	 115.9(2)	 O(3)‐C(11)‐C(12)	 110.6(2)	
C(1)‐C(10)‐O(3)	 118.3(2)	 C(7)‐N(2)‐C(9)	 117.5(2)	
C(1)‐C(10)‐C(9)	 122.3(2)	 C(14)‐C(13)‐C(12)	 119.2(2)	
O(3)‐C(10)‐C(9)	 119.2(2)	 C(6)‐C(5)‐C(4)	 119.3(2)	
N(2)‐C(9)‐C(10)		 117.7(2)		 N(2)‐C(7)‐C(6)	 123.6(3)	
N(2)‐C(9)‐C(4)	 123.0(2)	 C(10)‐C(1)‐C(2)	 119.2(2)	
C(10)‐C(9)‐C(4)		 119.3(2)	 C(16)‐C(17)‐C(12)	 120.0(3)	
O(1)‐N(1)‐O(2)		 123.1(2)	 C(3)‐C(2)‐C(1)		 120.3(2)	
O(1)‐N(1)‐C(3)	 118.7(2)	 C(15)‐C(14)‐C(13)		 121.3(3)	
O(2)‐N(1)‐C(3)	 118.1(3)	 C(15)‐C(14)‐Cl(1)	 119.8(2)	
C(13)‐C(12)‐C(17)		 119.8(2)	 C(13)‐C(14)‐Cl(1)		 118.9(2)	
C(13)‐C(12)‐C(11)		 121.3(2)	 C(5)‐C(6)‐C(7)	 120.0(3)	
C(17)‐C(12)‐C(11)		 118.9(2)	 C(15)‐C(16)‐C(17)	 120.9(3)	
C(2)‐C(3)‐C(4)	 122.8(2)	 C(16)‐C(15)‐C(14)	 118.9(2)	
	
Table	4.	Anisotropic	displacement	parameters	[Å2]	for	compound	1.	
Atom	 U11	 U22	 U33 U23 U13 U12	
Br(1)		 87	(1)	 101	(1)	 36	(1) 17	(1) 6	(1) ‐28	(1)	
O(3)		 49	(1)	 56	(1)	 24	(1) 2	(1) ‐3	(1) ‐13	(1)	
O(4)		 52	(1)	 58	(1)	 38	(1) 11	(1) 2	(1) ‐9	(1)	
O(1)		 58	(1)	 75	(1)	 74	(1) 12	(1) ‐25	(1) 13	(1)	
N(2)		 43	(1)	 39	(1)	 41	(1) 2	(1) ‐7	(1) 5	(1)	
N(1)		 41	(1)	 59	(1)	 43	(1) 9	(1) ‐11	(1) ‐3	(1)	
C	(12)	 41	(1)	 32	(1)	 29	(1) ‐4	(1) 1	(1) ‐1	(1)	
C	(3)	 36	(1)	 42	(1)	 33	(1)	 4	(1)	 ‐5	(1)	 ‐4	(1)	
C	(4)	 36	(1)	 33	(1)	 29	(1)	 3	(1)	 ‐1	(1)	 ‐5	(1)	
O	(2)	 82	(2)	 120	(2)	 50	(1)	 ‐23	(1)	 ‐27	(1)	 21	(2)	
C	(9)	 36	(1)	 30	(1)	 29	(1) 2	(1) ‐2	(1) ‐3	(1)	
C	(11)	 40	(1)	 38	(1)	 29	(1) ‐1	(1) 4	(1) 0	(1)	
C	(13)	 44	(1)	 40	(1)	 30	(1) 0	(1) ‐1	(1) ‐4	(1)	
C	(10)	 41	(1)	 43	(1)	 26	(1) 2 (1) ‐1	(1) ‐7	(1)	
C	(16)	 46	(1)	 63	(2)	 43	(1) ‐10	(1) ‐5	(1) ‐12	(1)	
C	(17)	 44	(1)	 50	(1)	 37	(1) ‐6	(1) 5	(1) ‐9	(1)	
C	(5)	 49	(1)	 47	(1)	 32	(1) ‐6	(1) 1	(1) ‐2	(1)	
C	(14)	 57	(1)	 41	(1)	 31	(1)	 2	(1)	 1	(1)	 ‐5	(1)	
C	(2)	 34	(1)	 56	(1)	 48	(1)	 2	(1)	 2	(1)	 7	(1)	
C	(15)	 55	(1)	 54	(1)	 31	(1) ‐3	(1) ‐9	(1) ‐2	(1)	
C	(1)	 45	(1)	 58	(2)	 39	(1)	 ‐5	(1)	 8	(1)	 2	(1)	
C	(7)	 44	(1)	 45	(1)	 60	(2)	 ‐5	(1)	 ‐1	(1)	 11	(1)	
C	(6)	 55	(2)	 52	(2)	 48	(1) ‐13	(1) 10	(1) 3	(1)	
	
Table	5.	Anisotropic	displacement	parameters	[Å2]	for	the	compound	2.	
Atom	 U11	 U22	 U33 U23 U13 U12	
Cl(1)		 110(1)	 118	(1)	 45	(1)	 21	(1)	 6	(1)	 ‐32	(1)	
O(3)		 51(1)	 65	(1)	 31	(1) 5	(1) ‐4	(1) ‐14	(1)	
C(4)		 38(1)	 40	(2)	 36	(1) 3	(1) ‐1	(1) ‐8	(1)	
O(4)		 54(1)	 65	(1)	 43	(1) 11	(1) 3	(1) ‐11	(1)	
C(10)		 41(1)	 52	(2)	 32	(1) 2	(1) ‐2	(1) ‐8	(1)	
C(9)		 37(1)	 40	(1)	 38	(1) 4	(1) ‐1	(1) ‐5	(1)	
N(1)		 45(1)	 68	(2)	 48	(1) 10	(1) ‐10	(1) ‐6	(1)	
C(12)		 43(1)	 40	(1)	 33	(1) ‐4	(1) 1	(1) 1	(1)	
C(3)		 37(1)	 49	(2)	 39	(1)	 7	(1)	 ‐4	(1)	 ‐6	(1)	
C(11)		 38	(1)	 47	(2)	 38	(1)	 ‐1	(1)	 4	(1)	 1	(1)	
N	(2)	 43	(1)	 	48	(1)	 52	(1)	 1	(1)	 ‐8	(1)	 3	(1)	
O	(2)	 56	(1)	 81	(2)	 84	(2) 16	(1) ‐24	(1) 10	(1)	
C	(13)	 50	(2)	 50	(2)	 38	(1) ‐2	(1) ‐2	(1) ‐6	(1)	
C	(5)	 55	(2)	 54	(2)	 37	(1) ‐4	(1) 2	(1) ‐7	(1)	
C	(7)	 47	(2)	 49	(2)	 70	(2) ‐7	(2) 4	(1) 6	(1)	
C	(1)	 48	(2)	 66	(2)	 41	(1) ‐6	(1) 9	(1) 3	(1)	
C	(17)	 49	(2)	 59	(2)	 43	(1) ‐6	(1) 3	(1) ‐8	(1)	
C	(2)	 37	(1)	 64	(2)	 52	(2) 2	(1) 3	(1) 6	(1)	
C	(14)	 69	(2)	 54	(2)	 38	(1)	 4	(1)	 2	(1)	 ‐4	(1)	
C	(6)	 55	(2)	 59	(2)	 58	(2)	 ‐14	(1)	 12	(1)	 1	(1)	
C	(16)	 50	(2)	 78	(2)	 50	(2) ‐12	(2) ‐8	(1) ‐8	(2)	
O	(1)	 80	(2)	 115	(2)	 53	(1)	 ‐16	(1)	 ‐23	(1)	 11	(1)	
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interaction	 is	 24.6%,	 to	 the	 crystal	 packing	 (Figure	 12)	 in	
compound	 1	 and	 25.1%	 in	 compound	 2	 (Figure	 13).	 Other	
important	 interactions	 for	 compound	 1	 are	 H···H	 (18.5	 %),	
C···H	(18.1%),	Br···H	(12.4%),	followed	by	weak	O···C	(6.9%),	
N···C	(3.4%),	and	N···H	(4.5%),	and	for	compound	2	are	H···H	








Compounds	1	 and	2	were	 evaluated	 for	 their	 for	 their	 in	
vitro	 antileishmanial	 activity	 against	 Leishmania	 Major	
promastigotes	 (Table	 7)	 and	 found	 as	 weak	 antileishmanial	
agents	with	IC50	values	73.2±3.1	and	72.2±2.3	g/mL,	respect‐
tively	against	the	standard	antileishmanial	drugs,	pentamidine	










































































































































































































































The	 in	 vitro	 antibacterial	 activity	 of	 compounds	1	 and	2	
against	 E.	 coli	 reference	 (ATCC25922	 and	 ATCC	 35218)	 and	
multi‐drug	 resistant	 (M2	 and	 M3)	 strains	 was	 also	 inves‐
tigated.	 Compounds	 1	 and	 2	 exhibited	 potent	 anti‐bacterial	
activity	against	E.	coli	reference	cell	 cultures	ATCC	35218	 (1,	







ATCC	25922		 ATCC	35218	 M2	 M3	
1	 91.42		 93.18		 93.59		 93.11		









The	 activity	 was	 found	 to	 be	 comparable	 to	 the	 tested	
standard	drugs,	ofloxacin	and	gentamycin	which	showed	96.75	
and	96.63%	 inhibition	 against	ATCC	35218	 and	ATCC	25922	
cell	cultures,	respectively.	Similarly	both	compounds	were	also	
appeared	 as	 potent	 anti‐bacterial	 agent	 against	E.	 coli	multi‐
drug	 resistant	 clinical	 isolates	 M2	 (1,	 93.59	 %	 inhibition,	 2,	
94.30	%	inhibition)	and	M3	(1,	93.11	%	inhibition,	2,	94.72	%	
inhibition).	 The	 activity	 was	 found	 to	 be	 comparable	 to	 the	
tested	 standard	 drugs	 gentamycin	 which	 showed	 97.20	 and	
92.07	%	inhibition	against	E.	coli	multi‐drug	resistant	clinical	
isolates	M2	and	M3,	respectively	while	ofloxacin	was	found	to	












using	 Hirshfeld	 surface	 analysis	 and	 fingerprint	 plots	 for	
compounds	1	 and	2	and	 found	 that	 the	 contribution	of	O···H	
intermolecular	 interactions	 is	 more	 than	 other	 (C···H,	 N···H,	
etc.)	 interactions	 towards	 crystal	 stability.	 The	 synthesized	
compounds	were	found	as	potent	anti‐bacterial	agents	against	
E.	 coli	 reference	 (ATCC25922	 and	 ATCC	 35218)	 and	 multi‐
drug	 resistant	 strains	 (M2	 and	 M3)	 and	 showed	 weak	 anti‐
leishmanial	 activity	 against	 L.	 Major	 promastigotes	 in	 vitro.	
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Crystallographic	 data	 for	 the	 structure	 reported	 in	 this	
article	 have	 been	 deposited	with	 Cambridge	 Crystallographic	
Data	 Center,	 CCDC	 1572291	 (Compound	 1)	 and	 CCDC	
1572292	 (Compound	 2).	 Copies	 of	 this	 information	
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